阿斯塔山丁对NAFLD的预防和治疗作用
Nor Hafiza Sayuti1, Khairul Najmi Muhammad Nawawi2,3, Jo Aan Goon1
1Department of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia, Bandar Tun Razak, Cheras, Kuala Lumpur 56000, Malaysia.
Antioxidants (Basel, Switzerland)
|August 26, 2023
概括
来自海洋来源的强有力的抗氧化剂阿斯塔克桑丁在对抗非酒精性脂肪肝疾病 (NAFLD) 中表现有前途. 这种胡卜素可以通过向关键疾病机制来预防或逆转NAFLD.
科学领域:
- 海洋生物学 海洋生物学
- 营养科学 营养科学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 影响全球30%的患者,这对公众健康构成重大挑战.
- 目前的NAFLD治疗方法有限,这促使人们寻找新的治疗策略.
- 阿斯塔克桑丁是一种海洋衍生的胡卜素,以其强大的抗氧化特性而闻名.
研究的目的:
- 审查阿斯塔山丁对NAFLD的潜在预防和治疗作用.
- 探索阿斯塔丁可能影响NAFLD进展的机制.
- 建立阿斯塔克桑丁在肝脏疾病中的临床应用的科学基础.
主要方法:
- 对调查阿斯塔克桑和NAFLD的研究进行文献综述.
- 分析阿斯塔克桑对氧化应激,炎症和胰岛素抵抗的影响.
- 检查阿斯塔山丁对脂质代谢和肝纤维化的影响.
主要成果:
- 阿斯塔丁显示出降低与NAFLD相关的氧化应激和炎症的潜力.
- 有证据表明,阿斯塔克桑可以改善胰岛素抵抗和脂质代谢.
- 该化合物在缓解肝纤维化方面表现有希望,这是NAFLD的一个关键并发症.
结论:
- 阿斯塔丁可以作为一种可行的治疗剂,用于预防或逆转NAFLD.
- 对阿斯塔克桑机制的进一步研究可以改进NAFLD治疗策略.
- 阿斯塔丁具有作为治疗慢性代谢性肝病的食补充剂的潜力.
关键词:
这是NAFLD.纳什·纳什 (Nash Nash) 是一个名为纳什的城市.抗氧化剂是一种抗氧化剂.这是一种阿斯塔克桑.胡卜素是一种胡卜素.肝脏疾病是一种肝脏疾病.非酒精性脂肪性肝病是非酒精性脂肪性肝病.非酒精性型肝炎的疾病.蒸汽症 (steatosis) 是一种疾病.更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
955
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
12.0K
相关概念视频
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
139
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
139
01:26Diseases of the Liver and Gallbladder
629
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
629
01:26Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12